{"transactions":[{"id":2249831,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-01T21:32:38.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on November 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":117,"derivative":{"exercise_price":2.66,"expiration_date":"2028-11-20","underlying":"Common Shares","underlying_shares":822},"source":{"system":"sec-edgar","filing":"0001209191-22-033336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919122033336/doc4.xml","form_type":"4"}},{"id":2249830,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-01T21:32:38.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":22870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":2659,"derivative":{"exercise_price":1.54,"expiration_date":"2028-10-15","underlying":"Common Shares","underlying_shares":22870},"source":{"system":"sec-edgar","filing":"0001209191-22-033336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919122033336/doc4.xml","form_type":"4"}},{"id":2249829,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-01T21:32:38.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":45072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.54,"expiration_date":"2027-07-21","underlying":"Common Shares","underlying_shares":45072},"source":{"system":"sec-edgar","filing":"0001209191-22-033336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919122033336/doc4.xml","form_type":"4"}},{"id":2249828,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-01T21:32:38.000Z","date":"2022-05-31","kind":"exercise","acquired":false,"shares":8016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.12,"expiration_date":"2025-08-26","underlying":"Common Shares","underlying_shares":8016},"source":{"system":"sec-edgar","filing":"0001209191-22-033336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919122033336/doc4.xml","form_type":"4"}},{"id":2249827,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-06-01T21:32:38.000Z","date":"2022-05-31","kind":"purchase","acquired":true,"shares":5000,"price":5.6,"value":28000.0,"ownership":{"direct":true},"balance_after":81780,"source":{"system":"sec-edgar","filing":"0001209191-22-033336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919122033336/doc4.xml","form_type":"4"}},{"id":2249826,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-06-01T21:32:38.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":822,"price":2.66,"value":2186.52,"ownership":{"direct":true},"balance_after":76780,"source":{"system":"sec-edgar","filing":"0001209191-22-033336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919122033336/doc4.xml","form_type":"4"}},{"id":2249825,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-06-01T21:32:38.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":22870,"price":1.54,"value":35219.8,"ownership":{"direct":true},"balance_after":75958,"source":{"system":"sec-edgar","filing":"0001209191-22-033336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919122033336/doc4.xml","form_type":"4"}},{"id":2249824,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-06-01T21:32:38.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":45072,"price":1.54,"value":69410.88,"ownership":{"direct":true},"balance_after":53088,"source":{"system":"sec-edgar","filing":"0001209191-22-033336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919122033336/doc4.xml","form_type":"4"}},{"id":2249823,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-06-01T21:32:38.000Z","date":"2022-05-31","kind":"exercise","acquired":true,"shares":8016,"price":1.12,"value":8977.92,"ownership":{"direct":true},"balance_after":8016,"source":{"system":"sec-edgar","filing":"0001209191-22-033336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919122033336/doc4.xml","form_type":"4"}},{"id":2622352,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-29T17:40:54.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":5.54,"expiration_date":"2031-06-14","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-048575","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919121048575/doc4.xml","form_type":"4"}},{"id":2892499,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T15:00:52.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly from January 1, 2021."}],"balance_after":32000,"derivative":{"exercise_price":5.78,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001333277-21-000025","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000133327721000025/edgar.xml","form_type":"4"}},{"id":3119041,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-08T19:10:06.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments over the 12 months commencing July 5, 2020, provided that the shares subject to this option shall vest in full on the date of Issuer's 2021 annual meeting of shareholders, subject to recipient continuing to provide service to the Issuer through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":3.74,"expiration_date":"2030-06-05","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-035120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919120035120/doc4.xml","form_type":"4"}},{"id":3143414,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-19T17:22:16.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":49245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 12 equal monthly installments commencing on January 31, 2020, subject to the Reporting Person's continuous service to the Issuer as of each such date."}],"balance_after":49245,"derivative":{"exercise_price":4.05,"expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":49245},"source":{"system":"sec-edgar","filing":"0001209191-20-030600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000120919120030600/doc4.xml","form_type":"4"}},{"id":3371729,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-14T18:41:00.000Z","date":"2019-11-12","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in equal monthly installments, beginning on December 12, 2019, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":4000,"derivative":{"exercise_price":17.78,"expiration_date":"2029-11-12","underlying":"Common Shares","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-19-056626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000120919119056626/doc4.xml","form_type":"4"}},{"id":3681493,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-31T17:22:50.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":27705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly from January 1, 2019."}],"balance_after":27705,"derivative":{"exercise_price":8.43,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":27705},"source":{"system":"sec-edgar","filing":"0001333277-19-000023","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000133327719000023/edgar.xml","form_type":"4"}},{"id":4088452,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-26T17:45:17.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly beginning January 1, 2018."}],"balance_after":16000,"derivative":{"exercise_price":11.69,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001333277-18-000031","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000133327718000031/edgar.xml","form_type":"4"}},{"id":4103391,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-09T06:35:32.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":84705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is granted pursuant to the Company's director compensation program and is for fiscal year ending December 31, 2018.  This option vests in 12 equal monthly installments.  The vesting commencement date is commensurate with the grant date of January 5, 2018."}],"balance_after":84705,"derivative":{"exercise_price":1.65,"expiration_date":"2028-01-05","underlying":"Common Stock","underlying_shares":84705},"source":{"system":"sec-edgar","filing":"0001214659-18-000292","document":"marketforms-40677.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465918000292/marketforms-40677.xml","form_type":"4"}},{"id":4103390,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-09T06:35:32.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":84705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is granted pursuant to the Company's director compensation program and is for fiscal year ending December 31, 2017.  This option vests in 12 equal monthly installments.  The vesting commencement date is April 27, 2017."}],"balance_after":84705,"derivative":{"exercise_price":1.65,"expiration_date":"2028-01-05","underlying":"Common Stock","underlying_shares":84705},"source":{"system":"sec-edgar","filing":"0001214659-18-000292","document":"marketforms-40677.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465918000292/marketforms-40677.xml","form_type":"4"}},{"id":4201683,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-26T11:27:31.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017, subject to the Reporting Person's continuous service to the Issuer as of each such date. The option allows for early exercise by the Reporting Person."}],"balance_after":7500,"derivative":{"exercise_price":7.47,"expiration_date":"2017-09-21","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-17-053912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000120919117053912/doc4.xml","form_type":"4"}},{"id":4214925,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T18:56:38.000Z","date":"2017-09-07","kind":"purchase","acquired":true,"shares":5000,"price":1.34,"value":6700.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares in the open market and through the 2005 Truex Family Trust u/d/t April 20, 2005.  Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017."}],"balance_after":16793,"source":{"system":"sec-edgar","filing":"0001214659-17-005551","document":"marketforms-39597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465917005551/marketforms-39597.xml","form_type":"4"}},{"id":4269475,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-30T14:32:59.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 12 equal monthly installments commencing on June 1, 2017."}],"balance_after":15000,"derivative":{"exercise_price":5.5,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001042074-17-000012","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000104207417000012/primary_doc.xml","form_type":"4"}},{"id":4312006,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chaiman"}}],"security":"Stock option (right to buy)","published_at":"2017-05-19T20:00:13.000Z","date":"2017-05-19","kind":"other","acquired":false,"shares":84376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 19, 2017, the reporting person and the Company agreed to cancel a stock option to purchase 84,376 shares of common stock dated May 17, 2013 (the \"option\"), which option was previously reported on a Form 4 filed with the SEC on May 21, 2013. This option was to vest annually over four years beginning March 25, 2013 (the Vesting Start Date). The Option would have completely vested on the fourth anniversary of the Vesting Start Date and would expire on May 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 19, 2017, the reporting person and the Company agreed to cancel a stock option to purchase 84,376 shares of common stock dated May 17, 2013 (the \"option\"), which option was previously reported on a Form 4 filed with the SEC on May 21, 2013. This option was to vest annually over four years beginning March 25, 2013 (the Vesting Start Date). The Option would have completely vested on the fourth anniversary of the Vesting Start Date and would expire on May 17, 2023."}],"balance_after":0,"derivative":{"exercise_price":39.04,"expiration_date":"2023-05-17","underlying":"Common Stock","underlying_shares":84376},"source":{"system":"sec-edgar","filing":"0001214659-17-003496","document":"marketforms-38868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465917003496/marketforms-38868.xml","form_type":"4"}},{"id":4312005,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chaiman"}}],"security":"Stock option (right to buy)","published_at":"2017-05-19T20:00:13.000Z","date":"2017-05-19","kind":"other","acquired":false,"shares":1369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 19, 2017, the reporting person and the Company agreed to cancel an outstanding stock option to purchase 1,369 shares of common stock dated February 18, 2009 (the \"option\"), which option was previously reported on a Form 4 filed with the SEC on February 23, 2010.  50% of the options were to vest monthly over four years beginning August 12, 2008 (the Vesting Start Date) and 50% of the options vested upon successful completion of milestones determined by the Board.  The options were fully vested on August 12, 2012.  The Option would expire on Feburary 18, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 19, 2017, the reporting person and the Company agreed to cancel an outstanding stock option to purchase 1,369 shares of common stock dated February 18, 2009 (the \"option\"), which option was previously reported on a Form 4 filed with the SEC on February 23, 2010.  50% of the options were to vest monthly over four years beginning August 12, 2008 (the Vesting Start Date) and 50% of the options vested upon successful completion of milestones determined by the Board.  The options were fully vested on August 12, 2012.  The Option would expire on Feburary 18, 2019."}],"balance_after":0,"derivative":{"exercise_price":96.64,"expiration_date":"2019-02-18","underlying":"Common Stock","underlying_shares":1369},"source":{"system":"sec-edgar","filing":"0001214659-17-003496","document":"marketforms-38868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465917003496/marketforms-38868.xml","form_type":"4"}},{"id":4484251,"issuer":{"id":92768,"kind":"organization","name":"CymaBay Therapeutics, Inc.","symbol":"CBAY"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-23T18:31:05.000Z","date":"2017-01-19","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three annual installments from the vesting start date of January 19, 2017."}],"balance_after":12000,"derivative":{"exercise_price":1.72,"expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-17-001192","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042074/000117911017001192/edgar.xml","form_type":"4"}},{"id":4531538,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2016-12-06T21:05:27.000Z","date":"2016-12-02","kind":"other","acquired":false,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 2, 2016, the Reporting Person and the Company agreed to cancel a stock option to purchase 180,000 shares of common stock dated September 17, 2015 (the \"Option\"), which Option was previously reported on a Form 4 filed with the SEC on September 18, 2015. This Option was to vest monthly over four years beginning September 17, 2015 (the \"Vesting Start Date\"). The Option would have completely vested on the fourth anniversary of the Vesting Start Date and would have expired on September 17, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 2, 2016, the Reporting Person and the Company agreed to cancel a stock option to purchase 180,000 shares of common stock dated September 17, 2015 (the \"Option\"), which Option was previously reported on a Form 4 filed with the SEC on September 18, 2015. This Option was to vest monthly over four years beginning September 17, 2015 (the \"Vesting Start Date\"). The Option would have completely vested on the fourth anniversary of the Vesting Start Date and would have expired on September 17, 2025."}],"balance_after":0,"derivative":{"exercise_price":9.48,"expiration_date":"2025-09-17","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001214659-16-015226","document":"marketforms-37311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465916015226/marketforms-37311.xml","form_type":"4"}},{"id":4531537,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock option (right to buy)","published_at":"2016-12-06T21:05:27.000Z","date":"2016-12-02","kind":"other","acquired":false,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 2, 2016, the Reporting Person and the Company agreed to cancel a stock option to purchase 170,000 shares of common stock dated September 17, 2015 (the \"Option\"), which Option was previously reported on a Form 4 filed with the SEC on September 18, 2015. The Option was to vest monthly over four years beginning December 30, 2014 (the \"Vesting Start Date\"). The Option would have completely vested on the fourth anniversary of the Vesting Start Date and would have expired on September 17, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 2, 2016, the Reporting Person and the Company agreed to cancel a stock option to purchase 170,000 shares of common stock dated September 17, 2015 (the \"Option\"), which Option was previously reported on a Form 4 filed with the SEC on September 18, 2015. The Option was to vest monthly over four years beginning December 30, 2014 (the \"Vesting Start Date\"). The Option would have completely vested on the fourth anniversary of the Vesting Start Date and would have expired on September 17, 2025."}],"balance_after":0,"derivative":{"exercise_price":9.48,"expiration_date":"2025-09-17","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001214659-16-015226","document":"marketforms-37311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465916015226/marketforms-37311.xml","form_type":"4"}},{"id":4597354,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-22T19:29:20.000Z","date":"2007-01-23","kind":"exercise","acquired":false,"shares":5008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 48 equal monthly installments from the vesting commencement date of October 3, 2005. This stock option was fully exercisable on October 3, 2009."}],"balance_after":25845,"derivative":{"exercise_price":2.08,"expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":5008},"source":{"system":"sec-edgar","filing":"0001214659-16-013774","document":"marketforms-36324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465916013774/marketforms-36324.xml","form_type":"4"}},{"id":4597353,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2016-09-22T19:29:20.000Z","date":"2016-09-20","kind":"gift","acquired":true,"shares":5008,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 20, 2016, the reporting person transferred 5,008 shares to the 2005 Truex Family Trust u/d/t April 20, 2005"}],"balance_after":94345,"source":{"system":"sec-edgar","filing":"0001214659-16-013774","document":"marketforms-36324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465916013774/marketforms-36324.xml","form_type":"4"}},{"id":4597352,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2016-09-22T19:29:20.000Z","date":"2016-09-20","kind":"gift","acquired":false,"shares":5008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 20, 2016, the reporting person transferred 5,008 shares to the 2005 Truex Family Trust u/d/t April 20, 2005"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001214659-16-013774","document":"marketforms-36324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465916013774/marketforms-36324.xml","form_type":"4"}},{"id":4597351,"issuer":{"id":163677,"kind":"organization","name":"Anthera Pharmaceuticals Inc","symbol":"ANTH"},"owners":[{"id":126702,"kind":"person","name":"TRUEX PAUL F","position":1,"cik":"0001120362","reported_name":"TRUEX PAUL F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2016-09-22T19:29:20.000Z","date":"2016-09-20","kind":"exercise","acquired":true,"shares":5008,"price":2.08,"value":10416.64,"ownership":{"direct":true},"balance_after":5008,"source":{"system":"sec-edgar","filing":"0001214659-16-013774","document":"marketforms-36324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1120362/000121465916013774/marketforms-36324.xml","form_type":"4"}}]}